Introduction Indian Renewable Energy Development Agency (IREDA) has recently announced significant growth in its loan sanctions and disbursements for the first quarter ending June 30, 2024. This blog delves into the key highlights and the remarkable performance of IREDA during this period. Record-Breaking Loan Sanctions and Disbursements IREDA has achieved a phenomenal growth in its …
Stocks/Share Market - Angel One

Overnight Digest: Top 5 Mid and Small-Cap Stocks to Watch for July 1
28 June 2024On Friday, the market experienced profit booking at record levels, causing it to close off intraday highs. The Sensex declined by 0.27% to close at 79,032.73, while the Nifty fell by 0.14% to settle at 24,010.60. Among the sectors, Nifty Pharma, Nifty Energy, and Nifty PSU Bank emerged as the top gainers. Conversely, Nifty Bank, …

Top 3 stocks trading below Rs 100
28 June 2024During Friday’s trading sessions, these three equities gained significantly with price and volume activity, indicating potential bullish action. Here’s an in-depth look. Ujjivan Small Finance Bank Ltd Ujjivan Small Finance Bank Ltd saw a significant price movement today, with its stock rising by 3.04% to Rs 45.11 from its previous close of Rs 43.78. The …

Tata Group Retains Top Spot in Brand Value Ranking, Indian Brands Showcase Growth
28 June 2024A new report by Brand Finance, a leading brand valuation consultancy, reveals continued dominance and promising growth within Indian brands. Tata Group Leads the Row Tata Group retains its position as India’s most valuable brand, boasting a brand value of USD 28.6 billion. This achievement marks a significant milestone, with Tata Group nearing the coveted …

Alembic Pharmaceuticals announces USFDA Final Approval for Doxycycline Capsules, 40 mg
28 June 2024On June 28th, 2024, Alembic Pharmaceuticals Limited disclosed receiving final approval from the US Food & Drug Administration (USFDA) for its Doxycycline Capsules, 40 mg. Doxycycline Capsules treat inflammatory skin lesions (papules and pustules) caused by rosacea in adults. The approval means Alembic’s version is equivalent in effectiveness to the reference drug, Oracea Capsules, 40 …

Bajaj Auto opens first-ever overseas facility in Brazil amid Exports Slump
28 June 2024Bajaj Auto, one of India’s leading exporters of motorcycles and three-wheelers, launched its first overseas manufacturing plant in Brazil. This setup was aided by its subsidiary Bajaj Do Brasil. With this initiative, Bajaj Auto aims to strengthen Bajaj’s position in Latin America’s largest 2-wheeler market by gaining insights into product development and consumer behavior. However, …

Top 5 Gainers of the Month from Nifty 500 – June 2024
28 June 2024There’s a saying, “As the days get longer in June, so do the opportunities in the stock market. Keep your eyes open and your strategies sharp.” This holds especially true for the Indian markets this year. At the start of June, the Indian stock market experienced significant volatility due to the exit poll euphoria followed …

Udupi Cochin Shipyard Ltd Secures Major Order from Wilson ASA
28 June 2024On June 28, 2024, Udupi Cochin Shipyard Limited (UCSL), a subsidiary of India’s leading shipyard Cochin Shipyard Limited (CSL), secured a significant international order from Wilson ASA of Norway. Details of the Contract The contract involves designing and building 4 Dry Cargo Vessels with a capacity of 6300 Metric Tonnes each. An agreement is also …

Vakrangee Strengthens ATM Play with Strategic Acquisition of 14.70% Vortex Engineering Stake
28 June 2024Vakrangee Limited, a leading technology-driven company focused on financial inclusion, announced a strategic investment to solidify its position in the ATM industry further. The company has signed an agreement to acquire an additional 14.70% equity stake in Vortex Engineering Private Limited (Vortex) from Oasis Capital (Mauritius) Limited. This acquisition increases Vakrangee’s total ownership in Vortex …

HCG Gains Control of Mahatma Gandhi Cancer Hospital in Strategic Partnership
28 June 2024HealthCare Global Enterprises Limited (HCG), one of India’s largest cancer care networks, has announced the acquisition of Mahatma Gandhi Cancer Hospital & Research Institute (MGCHRI) in Vizag, Andhra Pradesh, for an Enterprise Value of ₹4,140 million. Initially securing a 51% stake, HCG plans to acquire an additional 34% stake over the next 18 months. This …
- Ola Electric Accelerates Plans for ‘Raahi’ Electric Auto Rickshaw Launch
- Best ETFs in India in September 2024 – Based on 5yr CAGR
- India’s Noteworthy Mergers & Acquisitions Deals of FY24
- These 3 stocks from BSE 500 jumped over 6% today; do you own any?
- IDFC First Bank Announces Merger with IDFC Ltd.
